CRIPTO and neuroblastoma: Gene-wide promoter methylation profiling and cox elastic net analysis were utilized to predict NB patient outcome, and the degree of methylation of retinoblastoma 1 (RB1) and teratocarcinoma-derived growth factor 1 (TDGF1) was associated with poor survival39.